Electrical Stimulation in Denervated Muscles of the Upper Limbs
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | October 1, 2018 | ||
First Posted Date ICMJE | October 5, 2018 | ||
Last Update Posted Date | October 5, 2018 | ||
Actual Study Start Date ICMJE | September 1, 2018 | ||
Estimated Primary Completion Date | August 31, 2019 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
Pennation angle (degrees)[ Time Frame: Baseline and after 12 weeks of electrical stimulation ] Difference between the pennation angle of the stimulated muscle at baseline and after the stimulation period |
||
Original Primary Outcome Measures ICMJE | Same as current | ||
Current Secondary Outcome Measures ICMJE |
|
||
Descriptive Information | |||
Brief Title ICMJE | Electrical Stimulation in Denervated Muscles of the Upper Limbs |
||
Official Title ICMJE | Electrical Stimulation in Denervated Muscles of the Upper Limbs - Effect on Muscle Morphological Properties - A Pilot Study |
||
Brief Summary | In the last decade the stimulation of denervated muscles got more attention. Not at least because of the promising results of the RISE project (Use of electrical stimulation to restore standing in paraplegics with long-term denervated degenerated muscles). In this European project it was shown that electrical stimulation of denervated muscles in spinal cord injuries (SCI) increased muscle mass and improved the trophic situation of the lower extremities. Furthermore, structural altered muscle into fat- and connective tissue could be restored into contractile muscle tissue by stimulation. However, only a few studies investigated the effect of direct muscle stimulation in case of peripheral nerve damage in the upper extremities. None investigated the stimulation effect in denervated or partially denervated muscles in the upper extremities in tetraplegic patients. |
||
Detailed Description | In the last decade the stimulation of denervated muscles became part of the rehabilitation of spinal cord injuries (SCI). Not at least because of the promising results of the RISE project (Use of electrical stimulation to restore standing in paraplegics with long-term denervated degenerated muscles). In this European project it was shown that electrical stimulation of denervated muscles in SCI increased muscle mass and improved the trophic situation of the lower extremities. Furthermore, structural altered muscle into fat- and connective tissue could be restored into contractile muscle tissue by stimulation. However it has been shown that an extended time after SCI hinders the stimulation impact. The denervation process can be divided in four chronologically running steps. Muscle fibrillations are present some days after lesion followed by a loss of tension during electrical evoked tetanic contraction. After months a severe disorganization of the contractile structure in the muscle occurs and finally ends after years in a replacement of muscle fibers into fat tissue and collagen. The best results have been seen within three years after SCI. A stimulation protocol should be set up to start with single twitches combined with tetanic stimulation patterns according to the patients' improvements. The progression in stimulation training to elicit a tetanic contraction - 40 ms pulse duration with a pulse pause of 10 ms and bursts of 2 sec - could last some month in chronic stage after SCI. The stimulation of denervated muscles of the upper extremities gets more attention. It has been investigated that the cross sectional area of denervated muscle fibers could have been increased by early electrical stimulation. Furthermore, the changes in myosin heavy chain isoform, following denervation could be reversed. That indicates that early onset of stimulation could preserve the contractile muscle structure for possible reinnervation or further treatment options. Specially for tetraplegic patients who could benefit from nerve transfers, could win time for their decision. | ||
Study Type ICMJE | Interventional | ||
Study Phase | N/A | ||
Study Design ICMJE | Allocation: Intervention Model: Single Group Assignment Intervention Model Description: Repeated measurement interventional Single Subject Design Masking: Interventional Masking Description: Primary Purpose: Treatment |
||
Condition ICMJE | |||
Intervention ICMJE |
|
||
Study Arms |
|
||
Recruitment Information | |||
Recruitment Status ICMJE | Recruiting | ||
Estimated Enrollment ICMJE |
20 | ||
Original Estimated Enrollment ICMJE | Same as current | ||
Estimated Study Completion Date | November 30, 2019 | ||
Estimated Primary Completion Date | August 31, 2019 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria: - traumatic or non-traumatic spinal cord injury - acute and subacute (≥ 6 weeks) and chronic (≥ 2 years) spinal cord injury - Age ≥ 18 years - Level of lesion C3 - Th1 - American Spinal Injury Association Impairment Score (AIS) A/B/C/D - denervated M. extensor carpi ulnaris or M. abductor pollicis brevis or M. interosseus - Signed informed consent Exclusion Criteria: - innervated or partially innervated M. extensor carpi ulnaris or M. abductor pollicis brevis or M. interosseus - Patients' inability to follow the study, e.g. mental-health problems, language problems, dementia etc. - Pregnancy (anamnestic) | ||
Sex/Gender |
|
||
Ages | 18 Years and older (Adult, Older Adult) | ||
Accepts Healthy Volunteers | No | ||
Listed Location Countries ICMJE | Switzerland | ||
Removed Location Countries | |||
Administrative Information | Has Data Monitoring Committee | Yes | |
U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No |
||
IPD Sharing Statement |
|
||
Responsible Party | , | ||
Study Sponsor ICMJE | Swiss Paraplegic Centre Nottwil | ||
Collaborators ICMJE | |||
Investigators ICMJE |
|
||
PRS Account | |||
Verification Date | October 2018 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |